Page last updated: 2024-10-26

valproic acid and De Morsier Syndrome

valproic acid has been researched along with De Morsier Syndrome in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bini, P1
Montalbetti, L1
Tosca, P1
Ratti, MT1
Uggetti, C1
Moglia, A1
Costa, A1
Camino, R1
Arjona, A1

Other Studies

2 other studies available for valproic acid and De Morsier Syndrome

ArticleYear
Septo-optic dysplasia and psychiatric disorders: a case report.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2008, Volume: 21, Issue:4

    Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Female; Humans; Magnet

2008
Septo-optic dysplasia plus.
    The Lancet. Neurology, 2003, Volume: 2, Issue:7

    Topics: Adult; Anticonvulsants; Cerebral Cortex; Humans; Magnetic Resonance Imaging; Male; Radiography; Seiz

2003